FDAnews
www.fdanews.com/articles/71565-novoste-not-in-compliance-with-nasdaq

Novoste Not in Compliance With Nasdaq

April 26, 2005

Novoste faces delisting from the Nasdaq stock market because its stock has traded below the $1 a share minimum requirement for 30 days in a row. Nasdaq will give Norcross-based Novoste until Oct. 18 to regain compliance. In January, Novoste said it would soon decide the future of the company, which could include a shut down and liquidation. Novoste retained investment banking and strategic advisor Asante Partners in April 2004 to assist in its efforts to identify and implement strategic and financial alternatives.

Atlanta Business Chronicle (http://atlanta.bizjournals.com/atlanta/stories/2005/04/25/daily10.html)